We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current OPORF market cap is 236.28M. The company's latest EPS is EUR 0.0239 and P/E is 11.46.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 3.84M | 20.6M | 36.86M | 48.48M | 56.04M |
| Operating Income | -5.72M | -10.61M | 492k | 5.98M | 10.09M |
| Net Income | -6.54M | -10.79M | -74k | -776k | 16.12M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 10.63M | 48.55M | 42.27M | 51.38M | 83.23M |
| Total Liabilities | 7.28M | 26.25M | 21.59M | 31.16M | 48.9M |
| Total Equity | 3.35M | 22.3M | 20.68M | 20.22M | 34.33M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -3.25M | 4.17M | -1.56M | 15.98M | 17.24M |
| Investing | 487k | 1.18M | -739k | -1.36M | -5.18M |
| Financing | 3.82M | 13.04M | -1.2M | -1.83M | -3.52M |
| Market Cap | 236.28M |
| Price to Earnings Ratio | 11.46 |
| Price to Sales Ratio | 3.3 |
| Price to Cash Ratio | 5 |
| Price to Book Ratio | 5.39 |
| Dividend Yield | - |
| Shares Outstanding | 675.08M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 0.35 |
| 52 Week Low | 0.331 |
| Spread (Intraday) | 0.68 (97.63%) |
| Company Name | Open Orphan PLC (PK) |
| Address |
queen mary bioenterprises innovation centre london E1 2AX |
| Website | https://www.hvivo.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
